Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Ardian Inc |
---|---|
Information provided by: | Ardian Inc |
ClinicalTrials.gov Identifier: | NCT00753285 |
The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Device: Renal Denervation with a catheter-based procedure |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Renal Denervation in Patients With Refractory Hypertension |
Estimated Enrollment: | 20 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | December 2009 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Minnesota | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Bradley Bart, MD 612-873-3000 | |
Principal Investigator: Bradley Bart, MD |
Responsible Party: | Ardian, Inc. ( Craig Straley, Vice President Clinical Research ) |
Study ID Numbers: | TP-040 |
Study First Received: | September 12, 2008 |
Last Updated: | September 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00753285 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Vascular Diseases Hypertension |
Vascular Diseases Cardiovascular Diseases Hypertension |